These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 25580924)
1. Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study. Kertesz DP; Swartz MV; Tadger S; Plopski I; Barak Y Clin Neuropharmacol; 2015; 38(1):23-5. PubMed ID: 25580924 [TBL] [Abstract][Full Text] [Related]
2. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Chen JJ; Ondo WG; Dashtipour K; Swope DM Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259 [TBL] [Abstract][Full Text] [Related]
3. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Jankovic J; Clarence-Smith K Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129 [TBL] [Abstract][Full Text] [Related]
4. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Kenney C; Hunter C; Jankovic J Mov Disord; 2007 Jan; 22(2):193-7. PubMed ID: 17133512 [TBL] [Abstract][Full Text] [Related]
5. Tetrabenazine treatment for Huntington's disease-associated chorea. Ondo WG; Tintner R; Thomas M; Jankovic J Clin Neuropharmacol; 2002; 25(6):300-2. PubMed ID: 12469001 [TBL] [Abstract][Full Text] [Related]
6. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators. Frank S BMC Neurol; 2009 Dec; 9():62. PubMed ID: 20021666 [TBL] [Abstract][Full Text] [Related]
7. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769 [TBL] [Abstract][Full Text] [Related]
12. The long-term effect of tetrabenazine in the management of Huntington disease. Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408 [TBL] [Abstract][Full Text] [Related]
13. Tetrabenazine treatment in movement disorders. Paleacu D; Giladi N; Moore O; Stern A; Honigman S; Badarny S Clin Neuropharmacol; 2004; 27(5):230-3. PubMed ID: 15602104 [TBL] [Abstract][Full Text] [Related]
14. Tetrabenazine for the treatment of tardive dyskinesia. Leung JG; Breden EL Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088 [TBL] [Abstract][Full Text] [Related]
16. Sensory trick with metoclopramide-associated tardive tremor. Shprecher D BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22962383 [TBL] [Abstract][Full Text] [Related]
17. Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease. Kegelmeyer DA; Kloos AD; Fritz NE; Fiumedora MM; White SE; Kostyk SK J Neurol Sci; 2014 Dec; 347(1-2):219-23. PubMed ID: 25456459 [TBL] [Abstract][Full Text] [Related]